| 2020-DENG-69068 | |
| Researchers at Purdue University have developed a new biomimetic scaffolding material to regenerate skeletal muscle in the event of muscle damage due to injury. Current muscle regeneration techniques are often limited due to scarce tissue availability. Purdue researchers have created a new scaffold implant that promotes myoblast proliferation and myogenic differentiation to signal muscle growth. The scaffolding is comprised of hydrogels, including hyaluronic acid and chondroitin salt, that mimic the extracellular matrix of skeletal muscles and exhibit excellent cell-interactive properties as well as biodegradability and biocompatibility. The scaffolding material works to induce a natural regeneration process including inflammatory response, nerve innervation, and blood vessel formation directly at the site of an injury. In testing with mice, no signs of scar tissue, infection, edema, seroma, or toxicity were observed over the course of four weeks. Improved muscular regeneration response was observed in mice within just one week, which improved with exercise. Advantages: -Biocompatible -High Injury Recovery Rate -Improved Muscle Regeneration Potential Applications: -Muscle Regeneration -Regenerative Medicine Technology Validation: This technology has been tested in vivo with mice to observe injury recovery and biocompatibility. Recent Publication: Biomimetic Glycosaminoglycan-Based Scaffolds Improve Skeletal Muscle Regeneration in a Murine Volumetric Muscle Loss Model Journal of Bioactive Materials DOI: 10.1016/j.bioactmat.2020.10.012 |
|
|
|
|
Apr 19, 2021
Utility-Gov. Funding
United States
(None)
(None)
Jun 18, 2020
Provisional-Gov. Funding
United States
(None)
(None)
|
|
|
Purdue Office of Technology Commercialization The Convergence Center 101 Foundry Drive, Suite 2500 West Lafayette, IN 47906 Phone: (765) 588-3475 Fax: (765) 463-3486 Email: otcip@prf.org |
